Cargando…
Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations
We previously identified that the concentration of zeaxanthin in some commercially available carotenoid supplements did not agree with the product’s label claim. The conclusion of this previous work was that more quality assurance was needed to guarantee concordance between actual and declared conce...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691749/ https://www.ncbi.nlm.nih.gov/pubmed/29039801 http://dx.doi.org/10.3390/nu9101133 |
_version_ | 1783279854745026560 |
---|---|
author | Phelan, David Prado-Cabrero, Alfonso Nolan, John M. |
author_facet | Phelan, David Prado-Cabrero, Alfonso Nolan, John M. |
author_sort | Phelan, David |
collection | PubMed |
description | We previously identified that the concentration of zeaxanthin in some commercially available carotenoid supplements did not agree with the product’s label claim. The conclusion of this previous work was that more quality assurance was needed to guarantee concordance between actual and declared concentrations of these nutrients i.e., lutein (L) zeaxanthin (Z) and meso-zeaxanthin (MZ) in commercially available supplements. Since this publication, we performed further analyses using different commercially available macular carotenoid supplements. Three capsules from one batch of eight products were analysed at two different time points. The results have been alarming. All of the powder filled products (n = 3) analysed failed to comply with their label claim (L: 19–74%; Z: 57–73%; MZ: 83–97%); however, the oil filled soft gel products (n = 5) met or were above their label claim (L: 98–122%; Z: 117–162%; MZ: 97–319%). We also identified that the carotenoid content of the oil filled capsules were stable over time (e.g., L average percentage change: −1.7%), but the powder filled supplements degraded over time (e.g., L average percentage change: −17.2%). These data are consistent with our previous work, and emphasize the importance of using carotenoid interventions in oil based formulas rather than powder filled formulas. |
format | Online Article Text |
id | pubmed-5691749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56917492017-11-22 Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations Phelan, David Prado-Cabrero, Alfonso Nolan, John M. Nutrients Article We previously identified that the concentration of zeaxanthin in some commercially available carotenoid supplements did not agree with the product’s label claim. The conclusion of this previous work was that more quality assurance was needed to guarantee concordance between actual and declared concentrations of these nutrients i.e., lutein (L) zeaxanthin (Z) and meso-zeaxanthin (MZ) in commercially available supplements. Since this publication, we performed further analyses using different commercially available macular carotenoid supplements. Three capsules from one batch of eight products were analysed at two different time points. The results have been alarming. All of the powder filled products (n = 3) analysed failed to comply with their label claim (L: 19–74%; Z: 57–73%; MZ: 83–97%); however, the oil filled soft gel products (n = 5) met or were above their label claim (L: 98–122%; Z: 117–162%; MZ: 97–319%). We also identified that the carotenoid content of the oil filled capsules were stable over time (e.g., L average percentage change: −1.7%), but the powder filled supplements degraded over time (e.g., L average percentage change: −17.2%). These data are consistent with our previous work, and emphasize the importance of using carotenoid interventions in oil based formulas rather than powder filled formulas. MDPI 2017-10-17 /pmc/articles/PMC5691749/ /pubmed/29039801 http://dx.doi.org/10.3390/nu9101133 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Phelan, David Prado-Cabrero, Alfonso Nolan, John M. Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations |
title | Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations |
title_full | Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations |
title_fullStr | Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations |
title_full_unstemmed | Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations |
title_short | Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations |
title_sort | stability of commercially available macular carotenoid supplements in oil and powder formulations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691749/ https://www.ncbi.nlm.nih.gov/pubmed/29039801 http://dx.doi.org/10.3390/nu9101133 |
work_keys_str_mv | AT phelandavid stabilityofcommerciallyavailablemacularcarotenoidsupplementsinoilandpowderformulations AT pradocabreroalfonso stabilityofcommerciallyavailablemacularcarotenoidsupplementsinoilandpowderformulations AT nolanjohnm stabilityofcommerciallyavailablemacularcarotenoidsupplementsinoilandpowderformulations |